SCHEMBL3943365

SCHEMBL3943365

COc1ccc(C=O)cc1OCCc1ccc(C(F)(F)F)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 1/20 0.58
PPARA Q07869 1/20 0.58
MAPT P10636 7/20 0.56
NPSR1 Q6W5P4 2/20 0.56
LMNA P02545 1/20 0.56
HTT P42858 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
FDPS P14324 1/20 0.56
ALDH1A1 P00352 8/20 0.51
TSHR P16473 1/20 0.51
PDCD1 Q15116 1/20 0.47
CD274 Q9NZQ7 1/20 0.47
HPGD P15428 5/20 0.45
PTGES O14684 1/20 0.44
ALOX5 P09917 1/20 0.44
PPARG P37231 1/20 0.44
CYP2C9 P11712 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6582635 0.87 FDPS (0.61) MAPTNPSR1LMNAHTTSMN1; SMN2
SCHEMBL6229249 0.83 FDPS (0.63) MAPTNPSR1LMNAHTTSMN1; SMN2
SCHEMBL856842 0.82 ALDH1A1 (0.60) MAPTNPSR1LMNAHTTSMN1; SMN2
SCHEMBL12634629 0.81 MAPT (0.55) MAPTNPSR1LMNAHTTSMN1; SMN2
SCHEMBL27769528 0.80 MMP1 (0.47) PPARDPPARAMAPTSMN1; SMN2FDPS
SCHEMBL7661907 0.79 FDPS (0.86) MAPTNPSR1LMNAHTTSMN1; SMN2
SCHEMBL6504762 0.79 ALDH1A1 (0.48) PPARDPPARAMAPTNPSR1LMNA
SCHEMBL3944624 0.79 PPARD (0.55) PPARDPPARAMAPTLMNAHTT
SCHEMBL3944626 0.79 PPARD (0.55) PPARDPPARAMAPTLMNAHTT
SCHEMBL416228 0.78 ALDH1A1 (0.64) MAPTNPSR1LMNAHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1285908-B9 SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES KYORIN SEIYAKU KK (JP) 2009-04-22 EP disclosed
EP-1285908-B1 SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES KYORIN SEIYAKU KK (JP) 2008-09-10 EP disclosed
US-7049342-B2 Substituted phenylpropionic acid derivatives KYORIN PHARMACEUTICAL CO., LTD. (JP) 2006-05-23 US disclosed
US-20030187068-A1 Substituted phenylpropionic acid derivatives KYORIN PHARMACEUTICAL CO., LTD. (JP) 2003-10-02 US disclosed
EP-1285908-A1 SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES KYORIN PHARMACEUTICAL CO., LTD. (JP) 2003-02-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187068-A1 Substituted phenylpropionic acid derivatives PPARA, PPARG, PPARD PPARD 3/4885PPARA 1/4885MAPT 4172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.